Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial

Nita Bhandari(Society for Applied Studies), Temsunaro Rongsen‐Chandola(Society for Applied Studies), Ashish Bavdekar, Jacob John(Christian Medical College, Vellore), Kalpana Antony(Program for Appropriate Technology in Health), Sunita Taneja(Society for Applied Studies), Nidhi Goyal(Society for Applied Studies), Anand Kawade, Gagandeep Kang(Christian Medical College, Vellore), Sudeep Singh Rathore(Society for Applied Studies), Sanjay Juvekar, Jayaprakash Muliyil(Christian Medical College, Vellore), Alok Arya(Society for Applied Studies), Hanif Shaikh, Vinod Joseph Abraham(Christian Medical College, Vellore), Sudhanshu Vrati(Translational Health Science and Technology Institute), Michael A. Proschan(National Institutes of Health), Robert Kohberger, Georges Thiry, Roger I. Glass(National Institutes of Health), Harry B. Greenberg(Stanford University), George T. Curlin(National Institutes of Health), Krishna Mohan Surapaneni(Bharat Biotech (India)), G.V.J.A. Harshavardhan(Bharat Biotech (India)), Sai Prasad(Bharat Biotech (India)), T.S. Rao(Government of India), John W. Boslego(Program for Appropriate Technology in Health), Maharaj Kishan Bhan(Government of India)
The Lancet
March 14, 2014
Cited by 326

Abstract


Related Papers

No related papers found

Powered by citation graph analysis